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Setting: Two tertiary care hospitals and 12 peripheral 
health institutions (PHIs) in Trivandrum, Kerala, India.
Objective: To determine factors associated with the prev-
alence of diabetes mellitus (DM) among tuberculosis (TB) 
patients and examine differences in the proportion of 
new DM cases among TB patients diagnosed at tertiary 
care centres and PHIs.
Design: A descriptive study: TB patients diagnosed dur-
ing March–September 2012 were screened for known 
DM. Those with unknown DM status were tested for ran-
dom blood glucose and fasting blood glucose (FBG); FBG 
⩾ 126 mg/dl was diagnosed as new DM.
Results: Of 920 TB patients, 689 (72%) were male and 
the mean (standard deviation) age was 47.6 (16.4) years. 
Of these, 298 (32.4%) were diabetic: 235 (26%) had pre-
viously known DM and 63 (7%) were newly diagnosed. 
During the screening at PHIs and tertiary care hospitals, 
respectively 30/183 (16.4%) and 33/737 (4.5%) were 
newly diagnosed with DM (OR 3.71; 95%CI 2.17–6.32). 
Overall, age >50 years and pulmonary tuberculosis were 
independently associated with a higher prevalence of 
diabetes.
Conclusion: As nearly one in three TB patients had DM, 
we recommend that TB patients should be routinely 
screened for DM in Kerala. As the proportion of new DM 
was higher among TB patients diagnosed at PHIs, we 
would recommend that specific attention and investment 
be directed to PHIs.
India, the country with the highest number of tuber-culosis (TB) cases in the world (an estimated 2.2 mil-
lion cases in 2011),1 also has a very high burden of di-
abetes mellitus (DM), with an estimated 63 million 
cases in 2012.2 In India, 15% of pulmonary tuberculo-
sis (PTB) cases have been estimated to be attributable 
to DM.3 DM also affects TB treatment outcomes and 
may delay sputum conversion, increase case fatality 
rates during treatment, lead to increased failure rates 
in non-drug-resistant cases and also increase relapse 
rates of TB after successful completion of treatment.4,5 
Given this scenario, it has been felt that active screen-
ing for DM in TB patients may allow identiﬁ cation of 
previously undiagnosed DM and improve TB treat-
ment outcomes through improved DM care.
Diabetes is common in Kerala, a state in South India 
with a population of 34.6 million, with an estimated 
community prevalence of 16–20%.6,7 The state treated 
25 917 TB patients in 2012, including all types of TB.8 
Kerala is known to have a high prevalence of DM in 
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TB patients, with a recent study reporting a prevalence 
of 44%.9
As standardised procedures for DM screening 
among TB patients for use in hospitals and TB units 
(TUs)—a sub-district level tuberculosis programme 
management unit covering a population of 500 000, 
made up of varying numbers of peripheral health in-
stitutions (PHIs)—were not available in India, a moni-
toring tool linked to the TB registration and quarterly 
reporting system was developed and implemented, 
starting in multiple centres in India in 2012. The ﬁ nd-
ings of this pilot study10 showed that the screening 
procedures worked well, and the overall prevalence 
of DM in over 8000 screened TB patients was 13%. 
Trivandrum, in Kerala, was one of the sites that imple-
mented screening at both hospital and ﬁ eld level in 
the TU, allowing for comparison of the yield from the 
different levels of screening.
This study aimed to determine factors associated 
with the diagnosis of DM during screening of TB pa-
tients under programme conditions. Speciﬁ c objectives 
were to determine 1) the prevalence of DM, 2) the de-
mographic and clinical factors associated with preva-
lence of DM, and 3) whether the yield of newly diag-
nosed DM was different in tertiary care facilities 
compared to that in PHIs.
METHODS
Study design
This descriptive study was part of a national level im-
plementation project on bidirectional TB-DM screen-
ing performed within the routine health services in 
India in 2012.10
Study setting
The study was conducted in Trivandrum City in Ker-
ala, a state in the south of India. In 2012, 1750 smear-
positive TB patients were diagnosed and 2676 TB 
patients (including pulmonary smear-positive, pulmo-
nary smear-negative and extra-pulmonary TB) were 
registered for treatment in Trivandrum district.8 Accord-
ing to national guidelines,11 TB patients are classiﬁ ed 
as PTB based on sputum smear examination for acid-
fast bacilli (AFB) or, in those who are sputum smear-
negative, by chest radiograph within 2 weeks of the 
negative result being obtained. Extra-pulmonary TB 
cases are diagnosed by the treating doctor based on a 
combination of radiology, histopathology, demon-
stration of AFB by smear or culture and/or clinical fea-
tures. All TB patients are treated with a short-course, 
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fully intermittent (thrice weekly), standardised treat-
ment regimen containing rifampicin throughout, de-
livered under direct observation. 
The three centres that took part in the study in 
Trivandrum included two tertiary care hospitals and a 
TU consisting of 12 PHIs. The two hospitals were the 
Government Medical College Hospital, Trivandrum, 
and the Chest Disease Hospital, Pulayanarkotta. The 
Government Medical College Hospital is a 1916-bed, 
multi-specialty teaching hospital, with a daily out-
patient load of 1800 and approximately 850 cases of 
TB diagnosed annually. The Chest Disease Hospital, 
Pulayanarkotta, which caters for patients with respira-
tory diseases, including TB, has 508 beds and a daily 
out-patient load of about 60; some 325 TB patients 
are diagnosed and treated there every year. As TB care 
in India is mainly domiciliary, TB patients are referred 
to peripheral centres to continue their treatment, and 
the hospitals provide in-patient care only for the man-
agement of complications or co-morbidities. The ﬁ eld-
level programme management unit that participated 
in the study was the Trivandrum DTC (district TB cen-
tre) TU (covering a population of 0.5 million), which 
consists of 12 health care facilities, providing diagnosis 
of TB and directly observed treatment for TB patients. 
This unit registered 413 TB patients in 2012.
Trivandrum is the southernmost district of Kerala, 
with both a rural and an urban population. Patients are 
referred to the tertiary care hospitals from the PHIs or 
from private hospitals. Smaller PHIs are used by a pre-
dominantly rural population, whereas the tertiary care 
hospitals receive patients from both urban and rural 
areas. All of these hospitals provide free or subsidised 
care for patients. As a pulmonary care centre, the Chest 
Disease Hospital deals more with PTB, whereas the Gov-
ernment Medical College Hospital has various special-
ity departments providing care for extra-pulmonary 
TB patients.
Study participants
All TB patients aged ⩾15 years diagnosed consecutively 
at the two hospitals, or those registered for treatment 
at the Trivandrum DTC TU, between March and Sep-
tember 2012 made up the study population. The Chest 
Disease Hospital, Pulayanarkotta, started patient re-
cruitment on 15 March 2012 and the Medical College 
Hospital, Trivandrum, on 19 March 2012. DTC Trivan-
drum TU started recruiting cases from 1 April 2012.
Data collection and analysis
The methods of screening, recording and reporting 
have been described in detail elsewhere.10 Brieﬂ y, all 
TB patients were asked whether they had DM, and 
those with unknown DM status underwent random 
blood glucose (RBG) testing. If RBG was ⩾110 mg/dl, 
the patient was screened for fasting blood glucose 
(FBG). If FBG was ⩾126 mg/dl, DM was diagnosed. Ve-
nous blood samples were collected for blood sugar 
level measurement at the participating centre. Data on 
age, sex, smoking status (current smoker was deﬁ ned 
as a person who smoked in the last month), RBG and 
FBG values were collected in the TB-DM register, the 
study tool, by the ﬁ eld-level worker of the Revised Na-
tional TB Control Programme (RNTCP), and were 
cross-checked by the District TB Ofﬁ cer of Trivandrum, 
the Medical Ofﬁ cer of the Medical College RNTCP cell 
and the principal investigator. The main outcomes for 
analysis were the number and proportion (with 95% 
conﬁ dence interval [CI]) of TB patients with a diag-
nosis of DM (previously known and newly diagnosed), 
stratiﬁ ed by age, sex, place of diagnosis and type of TB. 
Bivariate analysis was conducted to examine whether 
those factors were associated with the prevalence of 
DM. Odds ratios (OR) with 95%CI were used to mea-
sure associations. Multivariate analysis using logistic 
regression was conducted to calculate the adjusted OR. 
Only those variables that were statistically signiﬁ cant 
(P < 0.05) in bivariate analysis were considered for 
multivariate analysis. EpiData Version 3.5.3 (EpiData 
Association, Odense, Denmark) was used to analyse 
the data.
Ethics approval
The study was approved by the Institutional Ethics 
Committee of Government Medical College, Trivan-
drum. As this was a pilot project aiming to test the fea-
sibility of DM screening among TB patients with a view 
to learning lessons for national scale-up approved by 
RNTCP authorities, the requirement for individual in-
formed consent was waived by the Institutional Ethics 
Committee. All diagnosed DM patients were linked to 
DM care. Permission to use, report and publish the 
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the International Union Against Tuberculosis and Lung 
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TABLE 1 Demographic and clinical profile of TB patients screened 
and prevalence of DM among these by site, Trivandrum, Kerala, 
India, March–September 2012
Category
All 
patients 
n (%)
CDH 
n (%)
MCH 
n (%)
DTC TU 
n (%) P value 
Total 920 (100) 313 (100) 424 (100) 183 (100)
Age, years
>50 407 (44) 173 (55) 143 (34)  91 (50) <0.01
⩽50 513 (56) 140 (45) 281 (66)  92 (50)
Sex
Male 670 (73) 264 (84) 274 (65) 132 (72) <0.01
Female 250 (27)  49 (16) 150 (35)  51 (28)
Current smoker
Yes 370 (41) 117 (38) 174 (42)  79 (41) 0.29
No 531 (59) 194 (62) 236 (58) 101 (59)
Type of TB
Pulmonary 545 (59) 245 (78) 167 (39) 133 (73) <0.01
Extra-pulmonary 375 (41)  68 (22) 261 (69)  50 (27)
DM
Yes 298 (32) 127 (43) 117 (28)  54 (30) <0.01
No 622 (68) 186 (60) 307 (72) 129 (71)
New DM (among 
DM cases only)
New  63 (21)  27 (21)   6 (5)  30 (56) <0.01
Previously 
diagnosed 235 (80) 100 (79) 111 (95)  24 (44)
TB = tuberculosis; DM = diabetes mellitus; CDH = Chest Disease Hospital; MCH = 
Medical College Hospital; DTC TU = district TB centre TB unit (consisting of 21 pe-
ripheral health institutions).
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RESULTS
A total of 948 TB patients were screened in all three sites. Of these, 
920 (97%) ﬁ nished the entire screening process, completing all 
their required blood measurements. These 920 patients were in-
cluded in the analysis. Of these, 670 (72%) were male and the 
mean (standard deviation) age was 47.8 (16.2) years. The median 
(interquartile range) age was 49 (37–59) years. The proﬁ le of the 
patients screened and the overall prevalence of DM among TB pa-
tients, desegregated by age, sex, smoking status and type of TB 
and for each site, are shown in Table 1. TB patients diagnosed at 
the Medical College Hospital had a higher proportion of extra-
pulmonary TB, females and those aged ⩽50 years. Of the 920 TB 
patients screened, 298 (32%) were diagnosed with DM. Of these, 63 
(21%) were newly diagnosed DM cases, whereas 235 (79%) had 
previously known DM. The proportion of new DM was higher 
among TB patients diagnosed at PHIs compared to those at ter-
tiary care hospitals.
Factors associated with a higher prevalence of DM among the 
TB patients are shown in Table 2. Age >50 years, male sex, PTB 
and current smoking were associated with higher prevalence of 
DM on bivariate analysis. In multivariate modelling, only age 
>50 years and PTB were found to be independently associated 
with DM.
Factors associated with the prevalence of new (previously un-
diagnosed) DM among the TB patients are shown in Table 3. Di-
agnosis in a PHI, age >50 years and PTB were found to be inde-
pendently associated with new DM after multivariate modelling.
DISCUSSION
We found a high prevalence of DM among TB patients treated in 
Trivandrum; it was signiﬁ cantly higher among those aged 
>50 years and in those with PTB. The prevalence of DM among 
the TB patients was higher in Trivandrum than in the other sites 
that took part in the pilot study (personal communication, SS): the 
overall prevalence of diabetes in TB patients in the nationwide pilot 
was 13%,10 whereas that in the Trivandrum centres was 32.4%. 
More than three quarters of the TB patients with DM knew 
their DM status before the screening; however, this proportion 
was lower among TB patients screened at PHIs. Among the TB pa-
tients screened at peripheral TU level, more than half the cases of 
DM diagnosed were new cases. This probably indicates that pa-
tients reaching the major hospitals have multiple opportunities 
for screening before the diagnosis of TB, whereas patients diag-
nosed with TB at peripheral level are likely to miss a diagnosis of 
DM if they do not undergo active screening after TB diagnosis.
The high prevalence of DM among TB patients in Trivandrum 
could be explained by the high prevalence of DM in the general 
population in Kerala, which, as reported by previous studies 
among the adult population, is 16–20%,6,7 and is much higher 
than in other states in India. TB patients in Kerala are also older 
than in other Indian states, which could be another reason for 
the high prevalence of DM in TB patients. The prevalence of TB is 
lower in Kerala than in the rest of the country.12,13 Kerala also has 
a lower prevalence of human immunodeﬁ ciency virus (HIV) infec-
tion in the general population compared to other states of South 
India: the prevalence of HIV in the general population of India is 
0.31% compared to 0.19% in Kerala.14 DM could therefore be one 
of the main factors driving the TB epidemic in Kerala, unlike 
other high TB burden countries.15
A study looking at the prevalence of DM in TB patients in Ker-
ala showed a high prevalence of DM, with 44% of TB patients 
having the disease.9 However, this prevalence was determined by 
glycated haemoglobin (HbA1c) testing, which is not feasible in 
ﬁ eld conditions. The use of the HbA1c measurement could also 
be the reason for the higher diagnosis of DM in TB patients. This 
study also showed that almost half the DM patients diagnosed on 
screening were unaware of their DM status at the time of screen-
ing, and they would have remained undiagnosed if the screening 
had not been undertaken. Factors associated with a diagnosis of 
DM in TB patients in that study were male sex and age >50 years. 
The strengths of this study are that a large number of TB pa-
tients were consecutively screened in the study sites in Trivan-
drum and are thus representative. Trivandrum was the only one 
TABLE 2 Factors associated with DM (previously and newly 
diagnosed) prevalence among TB patients, Trivandrum, Kerala, 
India, March–September 2012
Category
TB 
patients
n
Patients 
with DM
n (%) OR (95% CI)
Adjusted
OR (95%CI)*
Age, years
>50 418 182 (45) 2.8 (2.1–3.7)† 2.5 (1.9, 3.3)†
⩽50 530 116 (22)
Sex
Male 689 233 (34) 1.5 (1.1–2.1)† 1.0 (0.7, 1.5)
Female 259  65 (25)
Type of TB
Pulmonary 567 216 (38) 2.3 (1.7–3.1)† 1.9 (1.4, 2.7)†
Extra-pulmonary 383  82 (21)
Current smoker
Yes 377 144 (38) 1.6 (1.2–2.1)† 1.3 (0.96, 1.9)
No 546 152 (28)
Site of diagnosis
PHI 183  54 (30) 0.9 (0.6–1.2)
Tertiary care 737 244 (33)
* Adjusted for age, sex, type of TB and smoking status. 
† P < 0.05.
DM = diabetes mellitus; TB = tuberculosis; OR = odds ratio; CI = confidence interval; 
PHI = peripheral health institution.
TABLE 3 Factors associated with proportion of new DM among TB 
patients screened, Trivandrum, Kerala, India, March–September 2012
Category
TB 
patients
n
Patients
with newly 
diagnosed 
DM
n (%) OR (95%CI)
Adjusted 
OR (95%CI)*
Age, years
>50 407 41 (10.1) 2.5 (1.5– 4.3)† 2.2 (1.3, 3.8)†
⩽50 513 22 (4.3)
Sex
Male 668 48 (7.2) 1.2 (0.7–2.2) 0.98 (0.5, 2.0)
Female 252 15 (6)
Type of TB
Pulmonary 545 50 (9.2) 2.8 (1.5–5.3)† 2.1 (1.1, 4.1)†
Extra-pulmonary 375 13 (3.5)
Current smoker
Yes 370 28 (7.6) 1.2 (0.7–1.9) 0.9 (0.5, 1.7)
No 531 35 (6.6)
Site of diagnosis
PHI 183 30 (16.4) 4.2 (2.5–7.1)† 3.7 (2.2, 6.4)†
Tertiary care 737 33 (4.5)
* Adjusted for age, sex, type of TB, smoking status and site of diagnosis.
† P < 0.05.
DM = diabetes mellitus; TB = tuberculosis; OR = odds ratio; CI = confidence interval; 
PHI = peripheral health institution.
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of two cities where screening was performed at both tertiary care 
hospital and PHI level, allowing a comparison to be made be-
tween the two different sites of screening of the yield and propor-
tion of new DM diagnosed in the same population. Also, the use 
of a screening tool developed at national level allows for a com-
parison of the proportion of DM diagnosed in Trivandrum to that 
in other states in India. Possible limitations of the study include 
the lack of information on other possible confounding factors, as 
the information collected was limited to that included in the 
screening tool. Only patients notiﬁ ed to the RNCTP were included 
in the screening. There is a possibility that some patients, particu-
larly those with extra-pulmonary TB being treated with individu-
alised regimens outside the RNTCP, were not included in the study. 
This study has major policy implications. First, it demonstrates 
the feasibility of screening for DM in TB patients using a standard 
screening tool. Second, it reiterates the high prevalence of DM in 
TB patients in Kerala, highlighting once again the importance of 
DM as a risk factor for TB in Kerala. Third, it demonstrates that 
screening for DM in TB patients at ﬁ eld level results in a higher 
proportion of previously undiagnosed DM patients being detected, 
which shows the importance of early screening of TB patients at 
ﬁ eld level. The RNTCP can also support India’s non-communicable 
disease programme by early diagnosis of DM in a group of pa-
tients who would otherwise be undiagnosed, linking them to care 
and with a consequent reduction in morbidity and mortality. All 
of this requires close coordination between the RNTCP and the 
National Non-Communicable Disease Control Programme.
This study reinforces the view that DM screening in TB pa-
tients should be part of the minimum standard of care offered to 
all TB patients in Kerala and that it needs to be a high priority 
area for implementation. The state of Kerala has since taken a pol-
icy decision to screen all of its TB patients for DM. The govern-
ment of India subsequently also made this a policy for the rest 
of the country. In addition, steps have been taken to link the 
RNTCP and the National Non-Communicable Disease Control 
Programme at PHI level in Kerala, allowing for DM screening and 
improved care of TB patients diagnosed with DM.
CONCLUSION
This study conﬁ rms the high prevalence of DM in TB patients in 
Kerala and that a signiﬁ cant proportion of DM patients may not 
be aware of their status; screening for diabetes is thus an urgent 
requirement and a minimum standard of care for TB patients, par-
ticularly at ﬁ eld level.
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Contexte  :  Deux hôpitaux de soins tertiaires et 12 institutions péri-
phériques de santé (PHI) à Trivandrum, Kerala, Inde.
Objectif  :  Déterminer les facteurs en association avec la prévalence 
du diabète sucré (DM) chez les patients tuberculeux ( TB) et examiner 
la différence des proportions de nouveaux DM entre les patients TB 
diagnostiqués dans les centres de soins tertiaires et dans les PHI.
Schéma  :  Etude descriptive. On a dépisté un diabète déjà connu chez 
les patients TB diagnostiqués pendant la période de mars à septembre 
2012, et chez les patients dont le statut de DM était inconnu on a 
mesuré le glucose sanguin au hasard et le glucose sanguin à jeun 
(FBG) ; les sujets dont le FBG était ⩾ 126 mg/dl ont été diagnostiqués 
comme nouveaux cas de DM.
Résultats  :  Sur 920 patients TB, il y a eu 689 hommes (72%). Leur 
âge moyen était de 47,6 années (16,4). D’entre eux 298 (32,4%) 
étaient diabétiques ; 235 (26%) souffraient d’un DM déjà connu et 
63 (7%) ont été nouvellement diagnostiqués. Dans les PHI, 30/183 
(16,4%) ont été nouvellement diagnostiqués comme diabétiques au 
cours du dépistage et dans les hôpitaux de soins tertiaires 33/737 
(4,5%) l’ont été également (OR 3,71 ; IC 95% 2,17–6,32). Au total, 
un âge >50 ans et la TB pulmonaire sont en association indépen-
dante avec une prévalence plus élevée du DM.
Conclusion  :  La DM existe chez près d’un patient TB sur trois. Dès 
lors, nous recommandons le dépistage en routine du DM chez les pa-
tients TB de Kerala. La proportion de nouveaux cas de DM étant plus 
élevée chez les patients TB diagnostiqués dans les PHI, nous recom-
mandons dès lors qu’une attention et un investissement spécifiques 
soient portés à ce problème dans les PHI. 
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Marco de referencia: Dos hospitales de atención terciaria y 12 cen-
tros periféricos de atención de salud de Trivandrum, en el estado de 
Kerala en la India.
Objetivo: Determinar los factores que se asocian con la prevalencia 
de diabetes (DM) en los pacientes aquejados de tuberculosis (TB) y 
examinar las diferencias en la proporción de casos nuevos de DM di-
agnosticados en los establecimientos de atención terciaria y en los 
centros periféricos de salud. 
Métodos: Fue este un estudio descriptivo; se interrogó a los pacien-
tes con diagnóstico de TB establecido entre marzo y septiembre del 
2012 sobre el antecedente personal de DM y a los pacientes que 
desconocían su situación frente a la DM se practicaron pruebas de 
glucemia casual y glucemia en ayunas (FBG); el diagnóstico de un caso 
nuevo de diabetes se definió con una FBG ⩾ 126 mg/dl.
Resultados: De los 920 pacientes con TB, 689 eran de sexo mascu-
lino (72%) y la mediana de la edad fue 47,6 años (desviación estándar 
16,4 años). De estos pacientes, 298 eran diabéticos (32,4%), de ellos 
235 conocían su diagnóstico (26%) y se diagnosticaron 63 casos 
nuevos (7%). La proporción de casos nuevos diagnosticados en los 
centros periféricos fue de 30 en 183 pacientes (16,4%) y en los hos-
pitales de atención terciaria fue de 33 en 737 (4,5%) (OR 3,71; 
IC95% de 2,17 a 6,32). En general, una edad >50 años y la presencia 
de TB pulmonar fueron factores asociados de manera independiente 
con una mayor prevalencia de DM. 
Conclusión: Cerca de uno de cada tres pacientes TB presentaba DM; 
por esta razón se recomienda la detección sistemática de la DM en 
los pacientes con diagnóstico de TB en Kerala. La proporción de casos 
nuevos de DM fue mayor en los pacientes TB diagnosticados en los 
centros periféricos de atención sanitaria, por lo cual se preconiza 
prestar una mayor atención a este aspecto y realizar inversiones espe-
cíficas en estos centros.
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